Plasmodium vivax merozoite surface protein-3α: a high-resolution marker for genetic diversity studies by Surendra Kumar Prajapati et al.
J Vector Borne Dis 47, June 2010, pp. 85–90
Plasmodium vivax merozoite surface protein-3α: a high-resolution
marker for genetic diversity studies
Surendra Kumar Prajapati, Hema Joshi & Neena Valecha
National Institute of Malaria Research (ICMR), New Delhi, India
Abstract
Background & objectives: Malaria, an ancient human infectious disease caused by five species of
Plasmodium, among them Plasmodium vivax is the most widespread human malaria species and
causes huge morbidity to its host. Identification of genetic marker to resolve higher genetic diversity
for an ancient origin organism is a crucial task. We have analyzed genetic diversity of P. vivax
field isolates using highly polymorphic antigen gene merozoite surface protein-3alpha (msp-3α)
and assessed its suitability as high-resolution genetic marker for population genetic studies.
Methods: 27 P. vivax field isolates collected during chloroquine therapeutic efficacy study at Chennai
were analyzed for genetic diversity. PCR-RFLP was employed to assess the genetic variations
using highly polymorphic antigen gene msp-3α.
Results: We observed three distinct PCR alleles at msp-3α, and among them allele A showed
significantly high frequency (53%, χ2 = 8.22, p = 0.001). PCR-RFLP analysis revealed 14 and 17
distinct RFLP patterns for Hha1 and Alu1 enzymes respectively. Further, RFLP analysis revealed
that allele A at msp-3α is more diverse in the population compared with allele B and C. Combining
Hha1 and Alu1 RFLP patterns revealed 21 distinct genotypes among 22 isolates reflects higher
diversity resolution power of msp-3α in the field isolates.
Interpretation & conclusion: P. vivax isolates from Chennai region revealed substantial amount of
genetic diversity and comparison of allelic diversity with other antigen genes and microsatellites
suggesting that msp-3α could be a high-resolution marker for genetic diversity studies among P.
vivax field isolates.
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Introduction
The extensive polymorphism exhibited by surface
antigens is one of the major factors, why immunity
to malaria develops only after repeated infections with
the same species1. The genes encoding antigens are
under strong diversifying selection, i.e. an adaptive
mechanism to escape the host immune response2–5.
Understanding of the mechanisms generating varia-
tions in malaria surface antigens is essential for de-
signing immunization strategies to circumvent the
emergence of novel polymorphisms6.
PvMSP-3α, a 148–150 KDa merozoite protein be-
longs to Pvmsp-3 gene family. This gene family has
structurally related members, namely Pvmsp-3β, and
Pvmsp-3γ7,8. Pvmsp-3α is characterized by a distinct
block of alanine-rich heptad repeats in the central
region that are predicted to form an intramolecular
coiled-coil, and is polymorphic in nature. A number
of substitutions are reported to occur in or around
the heptad blocks, although the alanine-residue based
framework of the putative coiled-coil is conserved8,9.
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laria parasite throughout the globe except sub-Sa-
hara region of Africa where its prevalence is ex-
tremely low due to fixation of Duffy negativity trait
in African negro population10. In India, >50% an-
nual malaria cases are due to P. vivax. Understand-
ing towards genetic diversity and population struc-
ture of malaria parasites are the crucial steps to make
an effective anti-malarial control measure, and for
such studies identification of high diversity resolving
genetic markers are equally essential. In this paper,
genetic diversity of P. vivax field isolates from
Chennai and assessment of msp-3α as high diversity
resolving genetic marker are presented.
Material & Methods
Study site: Chennai (Tamil Nadu), a coastal metro-
politan city located in the southern region of the coun-
try has the problem of urban malaria. Large number
of overhead tanks in the city provide good condition
for mosquito breeding. Malaria is mainly due to P.
vivax (>90% of cases) and is being transmitted by
Anopheles stephensi (Diptera: Culicidae). Malaria
transmission is stable in Chennai and occurs through-
out the year. Recently, cases of chloroquine resis-
tant P. falciparum malaria are also being reported in
the Tamil Nadu state11.
Blood sample collection: Blood samples were col-
lected during P. vivax therapeutic efficacy study con-
ducted for chloroquine drug at Chennai Field Unit
of National Institute of Malaria Research (NIMR),
between 2003 and 2004. This study was approved
by the Ethics Committee of the NIMR, New Delhi.
All blood spots were collected with the consent of
the patients. Microscopically diagnosed P. vivax-
positive blood was spotted on autoclaved Whatman
filter paper strips and dried blood spots were stored
at 4°C. Blood smears were stained with JSB stain12
and examined at a 1000x magnification for identifi-
cation of P. vivax infection.
Genomic DNA extraction: The parasite DNA was
extracted from three punches of blood spots (3 mm)
on Whatman filter paper using the QIAamp DNA
Mini kit (Qiagen, Germany) as per manufacturer’s
instructions. Genomic DNA was eluted in autoclaved
double distilled water and stored at –20°C for fur-
ther use.
Amplification and restriction fragment length poly-
morphism (RFLP): PCR amplification and RFLP
protocols for msp-3α were reported elsewhere13.
PCR products were visualized on 1.0% agarose gel
and samples showing single PCR fragment were only
used for RFLP study. Five micro litres of PCR prod-
uct was digested individually with restriction enzymes
(Hha I and Alu I) at 37°C for 4 h. The restriction
products were visualized on 3.0% agarose gel fol-
lowed by fine genotyping of digested PCR products.
Results
PCR amplification of msp-3α and allele frequency:
Analysis of 27 P. vivax isolates from Chennai, India
revealed three PCR length variants A, B and C, and
their sizes were in the range of 1.8–2.0, 1.4–1.5 and
1.1–1.2 kb respectively (Fig. 1). In addition, we have
observed a fourth rare allele D with smaller frag-
ment size (0.5 kb) in a single isolate (Fig. 1). This
rare allele was previously observed in three monkey-
adapted strains of P. vivax, with a fragment size in
the range of 0.45–0.57 kb14. Two samples showed
multiple infections with variant A and B. For the cal-
culation of allele frequency, total number of obser-
vations for all alleles were considered instead of to-
Fig. 1: PCR amplified fragments of Pvmsp-3α gene from
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tal number of isolates. Overall, frequency distribu-
tion of the four variants A, B, C and D in field iso-
lates was 15/29, 5/29, 8/29 and 1/29 respectively.
This observation revealed that variant A is the domi-
nant allele in the isolates. Assuming a similar fre-
quency of the common msp-3α alleles in the popula-
tion, we have estimated expected allele frequency of
each allele to be 33%. Comparison of observed verses
expected allele frequency revealed biased distribution
of msp-3α alleles in the Chennai field isolates (χ2 = 9.47,
df = 2, p = 0.009) and allele A revealed significantly
higher allele frequency (53%, χ2 = 8.22, p = 0.001).
Restriction fragment length polymorphism (RFLP):
Among 27 P. vivax isolates, 22 were analyzed for
RFLP and the RFLP pattern of individual samples for
Table 1. Pvmsp-3α RFLP pattern (Alu 1 and Hha1 restriction enzymes) and genotyping among
 P. vivax isolates collected from Chennai, India
Sample Fragment Alu1 pattern (size in bp) Genotype Combined Genotype Hha1 pattern (size in bp)
ID size  (kb)  Alu1  genotype  Hha1
ch45 1.8 500 450 270 350 200 1 1 1 1000 500 450 275 250
ch8 1.4 500 200 150 2 2 2 1000 250
ch30 1.2 500 400 250 160 150 3 3 3 1000 200
ch105 1.2 500 300 190 150 4 4 3 1000 200
ch104 1.2 500 300 190 150 4 4 3 1000 200
ch106 1.4 500 200 190 150 5 5 3 1000 200
ch46 1.8 500 250 190 170 150 6 6 4 1000 320 250
ch112 1.8 500 420 200 190 7 7 5 1000 250 200
ch48 1.8 500 350 200 190 8 8 6 1000 400 250
ch45 1.8 500 320 200 9 9 7 1000 400
ch82 1.8 500 320 200 190 160 10 10 7 1000 400
ch33 1.8 500 420 250 190 150 11 11 8 1000 500 250 200
ch13 1.8 500 200 150 2 12 9 1000 400 250 200
ch83 1.8 500 320 250 200 190 12 13 9 1000 400 250 200
ch18 1.8 500 200 150 2 14 10 1000 500 400
ch12 1.8 500 360 200 190 160 13 15 11 1000 500 420
ch20 1.8 500 200 150 2 16 11 1000 500 420
ch81 1.8 500 250 190 150 14 17 11 1000 500 420
ch31 1.2 500 250 160 150 15 18 11 1000 500 420
ch84 1.2 500 250 200 160 150 16 19 12 1000 900 400 200
ch80 1.8 – – – – – – 20 13 1000 900 350 250 200
Ch107 1.8 500 400 200 190 150 17 21 14 1000 500
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individual enzymes is listed in Table 1 and Fig. 2. In
RFLP, 14 distinct Hha1 and 17 Alu1 RFLP patterns
were observed among 22 isolates. Distribution of indi-
vidual RFLP genotypes is shown in Fig. 3. Further, com-
bination of Hha1 and Alu1 patterns revealed a total of
21 distinct genotypes. RFLP pattern of P. vivax iso-
lates showed Alu1 is a better enzyme to uncover most
of the variations compared with Hha1. RFLP analysis
is also able to reveal differential level of diversity among
msp-3α alleles and variant A is more diverse in field
isolates compared to variants B and C (Table 1).
Discussion
This study presents genetic diversity among P. vivax
isolates collected from Chennai using a highly poly-
morphic genetic marker Pvmsp-3α. Present study re-
vealed high degree of genetic diversity among Indian P.
vivax isolates and msp-3α is highly polymorphic in the
population. This observation is in agreement with the
earlier studies, which showed high degree of genetic
variation at msp-3α in the field isolates of Delhi15 and
Kolkata16. Transmission of P. vivax in Delhi (seasonal),
Chennai (perennial), and Kolkata (low) is varied, how-
ever, genetic diversity level at msp-3α is in similar mag-
nitude suggesting msp-3α could be a potential genetic
marker. The observed enormous genetic diversity at
msp-3α is supported by earlier studies suggesting P.
vivax isolates are highly diverse using various category
of phenotypic and genetic markers such as infection
phenotypes, relapse pattern and clinical profiles, isoen-
zyme markers, antigen genes, and drug resistant gene
(reviewed by Joshi et al17). Substantial amount of ge-
netic polymorphism at msp-3α  have also been reported
from Thailand18, Papua New Guinea13, Korea19, Iran20
and South America14, thus, supporting high degree of
genetic polymorphism observed in the present study.
These observations suggest that high genetic diversity is
a rule of P. vivax isolates rather than exception. The
factors influencing higher genetic diversity at msp-3α
could be: (i) inter-allelic recombination14; and (ii) pres-
ence of polymorphism prone region such as alanine rich
heptad repeats.
Comparison of msp-3α alleles from Chennai field iso-
lates with Delhi and Kolkata P. vivax isolates revealed
similar distribution pattern, i.e. higher frequency of
allele A, however, it is variable in nature15,16. The
RFLP pattern of Delhi isolates revealed higher num-
ber of unique genotype like Chennai isolates. The
numbers of unique genotypes were less in Kolkata16
isolates compared to Delhi15 and Chennai isolates.
The difference in RFLP pattern could be due to dif-
ferent transmission patterns and sample collection
time. All the isolates from Delhi as well as from
Chennai were collected at a single time point (up to
a month) whereas isolates from Kolkata were col-
lected at several time points (up to a year). This prob-
ably increases the probability of getting higher num-
ber of common RFLP pattern.
Power of a genetic marker in terms of its ability to
uncover the existing genetic diversity of an organ-
ism in a population is of great concern especially for
selecting a marker for population genetic study. Com-
parison of genetic diversity at antigen genes in P.
vivax field isolates employing simple PCR or PCR-
RFLP methods for three antigen genes revealed 2–5
alleles at Pvgam-121–23, 11–23 at Pvcsp16,24 and 36
at Pvmsp-116 using substantial number of field iso-
lates (>100). Similarly, studies on microsatellites in
P. vivax field isolates revealed 5–18 alleles per lo-
cus25–27. Comparison of allelic diversity of the above
markers with the msp-3α revealed a higher resolu-
tion power of msp-3α (21 distinct genotypes among
22 field isolates) using simple PCR-RFLP method. This
suggests that msp-3α could be a very useful genetic
marker for the studies on: (i) molecular epidemiology,
Fig. 3: Distribution of Alu 1 and Hha 1 genotypes at Pvmsp-
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(ii) relapse infection, and (iii) differentiating recrudes-
cence from re-infection during drug efficacy study.
The present study concluded that Indian P. vivax iso-
lates displayed high diversity even in varied malaria en-
demicity using msp-3α. A high resolution power of msp-
3α suggests for its utility as a genetic marker for molecular
epidemiological and relapse/recrudescence studies.
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